Regulation of MDM2 E3 ligase activity by phosphorylation after DNA damage

Molecular and Cellular Biology

Volumn 31, Issue 24, 2011, Pages 4951-4963

  Cheng, Qian ^a   Cross, Brittany ^a   Li, Baozong ^a   Chen, Lihong ^a   Li, Zhenyu ^a   Chen, Jiandong ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; OLIGOMER; PROTEIN MDM2; PROTEIN P53; UBIQUITIN PROTEIN LIGASE E3;

ALLOSTERISM; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIMERIZATION; DNA DAMAGE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DOMAIN; PROTEIN FOLDING; RING FINGER MOTIF; UBIQUITINATION; UPREGULATION;

EID: 83255162746     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/mcb.05553-11     Document Type: Article

References (50)

1. Banin, S., et al. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677.
2. Barbash, O., et al. 2008. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer. Cancer Cell 14:68-78.
3. Blattner, C., T. Hay, D. W. Meek, and D. P. Lane. 2002. Hypophosphorylation of Mdm2 augments p53 stability. Mol. Cell. Biol. 22:6170-6182.
4. Brzovic, P. S., P. Rajagopal, D. W. Hoyt, M. C. King, and R. E. Klevit. 2001. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8:833-837.
5. Chao, C., et al. 2003. Cell type-and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. J. Biol. Chem. 278:41028-41033.
6. Chao, C., D. Herr, J. Chun, and Y. Xu. 2006. Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression. EMBO J. 25:2615-2622.
7. 1 by stabilizing p53. Genes Dev. 14:278-288.
8. Chen, J., V. Marechal, and A. J. Levine. 1993. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13:4107-4114.
9. Cheng, Q., L. Chen, Z. Li, W. S. Lane, and J. Chen. 2009. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity. EMBO J. 28: 3857-3867.
10. Cross, B., et al. 2011. Inhibition of p53 DNA binding function by the MDM2 protein acidic domain. J. Biol. Chem. 286:16018-16029.
11. Dang, J., et al. 2002. The RING domain of Mdm2 can inhibit cell proliferation. Cancer Res. 62:1222-1230.
12. Dornan, D., et al. 2004. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429:86-92.
13. Fang, S., J. P. Jensen, R. L. Ludwig, K. H. Vousden, and A. M. Weissman. 2000. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275:8945-8951.
14. Harris, S. L., and A. J. Levine. 2005. The p53 pathway: positive and negative feedback loops. Oncogene 24:2899-2908.
15. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
16. Honda, R., H. Tanaka, and H. Yasuda. 1997. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25-27.
17. Hu, C. D., Y. Chinenov, and T. K. Kerppola. 2002. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 9:789-798.
18. Jones, S. N., A. E. Roe, L. A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208.
19. Kawai, H., D. Wiederschain, and Z. M. Yuan. 2003. Critical contribution of the MDM2 acidic domain to p53 ubiquitination. Mol. Cell. Biol. 23:4939-4947.
20. Kostic, M., T. Matt, M. A. Martinez-Yamout, H. J. Dyson, and P. E. Wright. 2006. Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53. J. Mol. Biol. 363:433-450.
21. Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299-303.
22. Kulikov, R., K. A. Boehme, and C. Blattner. 2005. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance. Mol. Cell. Biol. 25:7170-7180.
23. Kulikov, R., M. Winter, and C. Blattner. 2006. Binding of p53 to the central domain of Mdm2 is regulated by phosphorylation. J. Biol. Chem. 281:28575-28583.
24. Leng, R. P., et al. 2003. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112:779-791.
25. Li, W., et al. 2009. Mechanistic insights into active site-associated polyubiquitination by the ubiquitin-conjugating enzyme Ube2g2. Proc. Natl. Acad. Sci. U. S. A. 106:3722-3727.
26. Linke, K., et al. 2008. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ. 15:841-848.
27. MacPherson, D., et al. 2004. Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23. EMBO J. 23:3689-3699.
28. Maki, C. G., and P. M. Howley. 1997. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell. Biol. 17:355-363.
29. Maya, R., et al. 2001. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15:1067-1077.
30. Mayo, L. D., J. J. Turchi, and S. J. Berberich. 1997. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. Cancer Res. 57:5013-5016.
31. Meulmeester, E., et al. 2003. Critical role for a central part of Mdm2 in the ubiquitylation of p53. Mol. Cell. Biol. 23:4929-4938.
32. Montes de Oca Luna, R., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203-206.
33. Phan, J., et al. 2010. Structure-based design of high-affinity peptides inhibiting the interaction of p53 with MDM2 and MDMX. J. Biol. Chem. 285: 2174-2183.
34. Poyurovsky, M. V., et al. 2007. The Mdm2 RING domain C terminus is required for supramolecular assembly and ubiquitin ligase activity. EMBO J. 26:90-101.
35. Prives, C., and P. A. Hall. 1999. The p53 pathway. J. Pathol. 187:112-126.
36. Sasaki, M., L. Nie, and C. G. Maki. 2007. MDM2 binding induces a conformational change in p53 that is opposed by heat-shock protein 90 and precedes p53 proteasomal degradation. J. Biol. Chem. 282:14626-14634.
37. Sherr, C. J. 2006. Divorcing ARF and p53: an unsettled case. Nat. Rev. Cancer 6:663-673.
38. Shieh, S. Y., J. Ahn, K. Tamai, Y. Taya, and C. Prives. 2000. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14:289-300.
39. Shieh, S. Y., M. Ikeda, Y. Taya, and C. Prives. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334.
40. Shinozaki, T., A. Nota, Y. Taya, and K. Okamoto. 2003. Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export. Oncogene 22:8870-8880.
41. Sionov, R. V., et al. 2001. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Mol. Cell. Biol. 21:5869-5878.
42. Sivakolundu, S. G., et al. 2008. Intrinsically unstructured domains of Arf and Hdm2 form bimolecular oligomeric structures in vitro and in vivo. J. Mol. Biol. 384:240-254.
43. Tang, X., et al. 2007. Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination. Cell 129:1165-1176.
44. Tanimura, S., et al. 1999. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett. 447:5-9.
45. Uldrijan, S., W. J. Pannekoek, and K. H. Vousden. 2007. An essential function of the extreme C terminus of MDM2 can be provided by MDMX. EMBO J. 26:102-112.
46. Wallace, M., E. Worrall, S. Pettersson, T. R. Hupp, and K. L. Ball. 2006. Dual-site regulation of MDM2 E3-ubiquitin ligase activity. Mol. Cell 23:251-263.
47. Wawrzynow, B., et al. 2009. A function for the RING finger domain in the allosteric control of MDM2 conformation and activity. J. Biol. Chem. 284: 11517-11530.
48. Yu, G. W., et al. 2006. The central region of HDM2 provides a second binding site for p53. Proc. Natl. Acad. Sci. U. S. A. 103:1227-1232.
49. Zhang, L., et al. 2011. The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. Genes Dev. 25:1262-1274.
50. Zhang, Y., and H. Lu. 2009. Signaling to p53: ribosomal proteins find their way. Cancer Cell 16:369-377.